Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry A Allen

Showing results (291-300 of 401) with videos related to

Pageof 41
Sort By:
European Journal of Heart Failure|August 26, 2023
Sex differences in long-term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines-Heart Failure registryNeil Keshvani, Sonia Shah, Iyanuoluwa Ayodele, et al.
Circulation. Heart Failure|December 2, 2022
Assessing Heuristic Bias During Care for Patients Hospitalized for Heart Failure: Get With The Guidelines-Heart FailureSenthil Selvaraj, Stephen J Greene, Iyanuoluwa Ayodele, et al.
The American Journal of Cardiology|September 4, 2023
Potential Applicability of Omecamtiv Mecarbil to Patients Hospitalized for Worsening Heart FailureJosephine Harrington, Jie-Lena Sun, Gregg C Fonarow, et al.
Journal of the American Heart Association|February 27, 2023
Group Dynamics and Allocation of Advanced Heart Failure Therapies-Heart Transplants and Ventricular Assist Devices-By Gender, Racial, and Ethnic GroupKhadijah Breathett, Ryan Yee, Natalie Pool, et al.
Journal of the American Heart Association|June 20, 2022
Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart FailureBirju R Rao, Candace D Speight, Larry A Allen, et al.
American Heart Journal|September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Circulation. Heart Failure|July 24, 2020
Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results From a Multicenter SurveyMarc D Samsky, Adam D DeVore, Colleen K McIlvennan, et al.
Journal of Medical Internet Research|September 25, 2025
Application of Nudges to Design Clinical Decision Support Tools: Systematic Approach Guided by Implementation ScienceKaty E Trinkley, Danielle Maestas Duran, Shelley Zhang, et al.
Circulation. Heart Failure|October 31, 2022
Adoption of Sacubitril/Valsartan Among Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The Get With The Guidelines-Heart Failure RegistryJacob B Pierce, Zhen Li, Melissa A Greiner, et al.
Journal of Cardiac Failure|June 9, 2019
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of AmericaShannon M Dunlay, Michael M Givertz, David Aguilar, et al.
Pageof 41

Showing results (291-300 of 401) with videos related to

Sort By:
Pageof 41
European Journal of Heart Failure|August 26, 2023
Sex differences in long-term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines-Heart Failure registryNeil Keshvani, Sonia Shah, Iyanuoluwa Ayodele, et al.
Circulation. Heart Failure|December 2, 2022
Assessing Heuristic Bias During Care for Patients Hospitalized for Heart Failure: Get With The Guidelines-Heart FailureSenthil Selvaraj, Stephen J Greene, Iyanuoluwa Ayodele, et al.
The American Journal of Cardiology|September 4, 2023
Potential Applicability of Omecamtiv Mecarbil to Patients Hospitalized for Worsening Heart FailureJosephine Harrington, Jie-Lena Sun, Gregg C Fonarow, et al.
Journal of the American Heart Association|February 27, 2023
Group Dynamics and Allocation of Advanced Heart Failure Therapies-Heart Transplants and Ventricular Assist Devices-By Gender, Racial, and Ethnic GroupKhadijah Breathett, Ryan Yee, Natalie Pool, et al.
Journal of the American Heart Association|June 20, 2022
Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart FailureBirju R Rao, Candace D Speight, Larry A Allen, et al.
American Heart Journal|September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Circulation. Heart Failure|July 24, 2020
Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results From a Multicenter SurveyMarc D Samsky, Adam D DeVore, Colleen K McIlvennan, et al.
Journal of Medical Internet Research|September 25, 2025
Application of Nudges to Design Clinical Decision Support Tools: Systematic Approach Guided by Implementation ScienceKaty E Trinkley, Danielle Maestas Duran, Shelley Zhang, et al.
Circulation. Heart Failure|October 31, 2022
Adoption of Sacubitril/Valsartan Among Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The Get With The Guidelines-Heart Failure RegistryJacob B Pierce, Zhen Li, Melissa A Greiner, et al.
Journal of Cardiac Failure|June 9, 2019
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of AmericaShannon M Dunlay, Michael M Givertz, David Aguilar, et al.
Pageof 41